The purpose of the Eastern Allergy Conference (EAC) CME Program is to plan and create educational activities and enduring material that will develop, maintain, update, and enhance the clinical practice of allergy, asthma, and immunology. The overall educational goal is to share clinically relevant information that improves the diagnostic accuracy and the effectiveness of treatments with practitioners who treat allergies, asthma, and the immune system.
EAC was established in 1987, when Dr. Guy A. Settipane recognized the need for a regional conference on a larger scale than those that existed at the time. His vision was to combine the informal atmosphere of a small regional meeting with the cutting-edge scientific content characteristic of a major national conference. The inaugural EAC was held at the Southampton Princess in Bermuda and was an outstanding success. Since then, the conference has continued to uphold its tradition of merging a high-quality scientific program with an informal atmosphere in a desirable location.
The Eastern Allergy Conference is a 501(c)(3) nonprofit organization, tax ID #: 05-0515560.

Dr. Bellanti is Professor of Pediatrics and Microbiology-Immunology, Emeritus, and Director of the International Center for Interdisciplinary Studies of Immunology (ICISI) at Georgetown University Medical Center. He earned his MD from the University at Buffalo and completed residency training at Children’s Hospital of Buffalo, followed by
Dr. Bellanti is Professor of Pediatrics and Microbiology-Immunology, Emeritus, and Director of the International Center for Interdisciplinary Studies of Immunology (ICISI) at Georgetown University Medical Center. He earned his MD from the University at Buffalo and completed residency training at Children’s Hospital of Buffalo, followed by postdoctoral training in developmental immunology at the University of Florida and viral immunology at Walter Reed Army Institute of Research.
His research has advanced antimicrobial science, vaccine development, and developmental immunology, including seminal work characterizing the newborn IgM response, defining the antiviral role of secretory IgA in respiratory secretions, and elucidating cellular immune responses to viral infections.
Dr. Bellanti has received numerous national honors and has served as President of several leading organizations, including the American College of Allergy, Asthma and Immunology (ACAAI), InterAsma (1987-1990), the Society for Pediatric Research (SPR) (1980-1981) and American Board of Allergy and Immunology (ABAI) (1975-1980).
He has authored over 500 scientific publications and a widely recognized immunology textbook. Dr. Bellanti has served as Editor-in-Chief of Pediatric Research (1977–1983), Annals of Allergy (1982–1990), and currently Allergy and Asthma Proceedings (2004–present). He has authored over 500 scientific publications and a widely recognized immunology textbook, and has led several national and international professional organizations.

Dr. Corrao, Clinical Professor of Medicine Emeritus at the Warren Alpert Medical School of Brown University, and founding partner of University Pulmonary Associates of East Greenwich, RI, currently serves as Clinical Affiliate Professor at Florida Atlantic University, Schmidt College of Medicine, donating services to West Palm Beach Veter
Dr. Corrao, Clinical Professor of Medicine Emeritus at the Warren Alpert Medical School of Brown University, and founding partner of University Pulmonary Associates of East Greenwich, RI, currently serves as Clinical Affiliate Professor at Florida Atlantic University, Schmidt College of Medicine, donating services to West Palm Beach Veterans’ Hospital and the RI Free Clinic.
Dr. Corrao has been internationally recognized as lead author of the landmark study in the New England Journal of Medicine, “Cough as sole presenting symptom of asthma.” As an authority in his field, he has taught and lectured all through the world, including India, Russia, Greece, Japan, Hong Kong, Spain, Thailand, and Indonesia, as well as throughout the US.
Dr. Corrao has been honored as “Outstanding Physician of RI,” by the American Thoracic Society. In addition, he is the recipient of numerous Excellence in Teaching, and RI Monthly Top Physician awards.
Dr. Corrao has been a Governor of the ACCP, and served on numerous hospital and charitable boards. He currently sits on the board of the Eastern Allergy Conferences, serves as reviewer of “Allergy & Asthma Proceedings” and consults to Brigham & Women’s Pulmonary Associates of Care New England.

Dr. Sandra Gawchik is a clinical and academic leader specializing in allergy, clinical immunology, and pediatrics. She currently serves as a Clinical Associate Professor of Pediatrics at Thomas Jefferson University Hospital and previously served as President and Principal Investigator at Asthma and Allergy Research Associates from 1994 to
Dr. Sandra Gawchik is a clinical and academic leader specializing in allergy, clinical immunology, and pediatrics. She currently serves as a Clinical Associate Professor of Pediatrics at Thomas Jefferson University Hospital and previously served as President and Principal Investigator at Asthma and Allergy Research Associates from 1994 to 2022.
Dr. Gawchik has demonstrated extensive leadership within prominent medical organizations. She is a past President of the Pennsylvania Allergy Association, the Philadelphia Allergy Association, and the American Association of Certified Allergists. She also served as President of the Regional, State, and Local Allergy Society of the American Academy of Allergy, Asthma & Immunology (AAAAI). She currently serves as Chairperson of the Urticaria Subcommittee within the AAAAI Dermatology Committee and is a past Chair of the Women in Allergy Committee for the American College of Allergy, Asthma and Immunology (ACAAI).
In recognition of her contributions to the field, Dr. Gawchik received the ACAAI Women in Allergy Award in 2017. Her career reflects a longstanding commitment to patient care, medical education, and advancing research in allergy and immunology.

Dr. William Greisner is a graduate of Eastern Virginia Medical School, Norfolk, Virginia. He trained in internal medicine at the Medical Center Hospital of Vermont and completed his pediatric and adult allergy and clinical immunology fellowship at Brown University, Providence, Rhode Island.
Dr. Greisner is board certified in internal medic
Dr. William Greisner is a graduate of Eastern Virginia Medical School, Norfolk, Virginia. He trained in internal medicine at the Medical Center Hospital of Vermont and completed his pediatric and adult allergy and clinical immunology fellowship at Brown University, Providence, Rhode Island.
Dr. Greisner is board certified in internal medicine, and allergy and clinical immunology. He is the owner of Bluegrass Allergy Care where he has been practicing for 30 years. Dr. Greisner participates in phase I-IV clinical trials and is the owner of Bluegrass Allergy Research. He is also a registered pharmacist.
Dr. Greisner currently serves as Chief of Allergy at Saint Joseph Hospital, and President of the Blue Grass Society of Allergy & Asthma in Lexington, Kentucky, and is on the board for the Eastern Allergy Conference. He is a member of the American Academy of Allergy, Asthma & Immunology and the American College of Allergy, Asthma & Immunology.

Dr. Robert Settipane earned his undergraduate degree from Brown University where he majored in Biology. He earned his Medical Doctor (MD) degree from New York Medical College, which he attended from 1981 to 1985. He then completed an internship and residency at the University of Connecticut from 1988 to 1990.
Dr. Robert Settipane undertoo
Dr. Robert Settipane earned his undergraduate degree from Brown University where he majored in Biology. He earned his Medical Doctor (MD) degree from New York Medical College, which he attended from 1981 to 1985. He then completed an internship and residency at the University of Connecticut from 1988 to 1990.
Dr. Robert Settipane undertook two additional years of fellowship training in adult and pediatric allergy, asthma and immunology through Brown University’s Allergy/Immunology fellowship program at Rhode Island Hospital.
In 1991, Dr. Robert Settipane became Board Certified by the American Board of Allergy and Immunology, and has maintained certification since then. . He has been in full time private practice since 1990. He has authored a variety of original research papers including the frequently cited 23 year follow-up of Brown University College students which established allergic rhinitis as a significant risk factor for the subsequent development of asthma.
Dr. Robert Settipane sees both adult and pediatric patients with allergic nasal, ocular, lung and skin conditions including asthma, eczema and hives.
Dr. Robert Settipane has a special interest is cost effective healthcare and actively seeks to reduce his patient’s healthcare expense in a variety of ways.

Dr. Russell Settipane, co-director of the Allergy and Asthma Centers in East Providence, Rhode Island, is a Clinical Professor of Medicine at the Warren Alpert Medical School of Brown University. His allergy and immunology fellowship was completed at Scripps Clinic and Research Foundation in La Jolla, CA.
He has participated in over 100 c
Dr. Russell Settipane, co-director of the Allergy and Asthma Centers in East Providence, Rhode Island, is a Clinical Professor of Medicine at the Warren Alpert Medical School of Brown University. His allergy and immunology fellowship was completed at Scripps Clinic and Research Foundation in La Jolla, CA.
He has participated in over 100 clinical trials and has authored more than 150 scientific articles, reviews, and book chapters in the field of allergy & immunology.
Currently, he serves as President of the Rhode Island Society of Allergy, the American Association of Certified Allergists, and the Eastern Allergy Conference.

Following a decorated 30-year career as a Senior Medical Science Director of Immunology (US Medical Affairs), a Senior Director of Strategic Partnerships, and a National Sales Director (Allergy & Immunology) at Genentech, Inc, Kelli turned her focus to the world of addiction recovery.
Since then, Kelli has worked with her brother, NHL lege
Following a decorated 30-year career as a Senior Medical Science Director of Immunology (US Medical Affairs), a Senior Director of Strategic Partnerships, and a National Sales Director (Allergy & Immunology) at Genentech, Inc, Kelli turned her focus to the world of addiction recovery.
Since then, Kelli has worked with her brother, NHL legend Kevin Stevens, as the President/CEO and Co-Founder of Power Forward, Inc., a 501c3 nonprofit organization whose mission is to de-stigmatize addiction through education, empowerment and innovation.
Kelli’s Board leadership experiences include past Chairperson
of the Allergy & Asthma Foundation of America (AAFA) in
Washington, D.C. and Chair of the AAFA Governance
Committee for six years. She has been serving as Secretary of
the Eastern Allergy Conference Board of Directors for the past
ten years.
For review articles and abstracts from EAC, visit Allergy & Asthma Proceedings
© 2026 EAC. All Rights Reserved.